High-resolution whole-brain magnetic resonance spectroscopic imaging in youth at risk for psychosis
Imaging Neuroscience · 17.06.2026 · 4
DOI: 10.1162/imag.a.1276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Imaging Neuroscience, online erschienen am 17.06.2026. Verfasst von Edgar Céléreau und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Faculté de Biologie et de Médecine, Université de Lausanne, Adrian & Simone Frutiger Foundation.
Abstract (Originalsprache)
Advances in three-dimensional magnetic resonance spectroscopic imaging (3D-MRSI) allow for the high-resolution mapping of multiple neurometabolites throughout the entire brain in vivo and within clinically compatible time frames. Leveraging this capability, we created a voxel-based pipeline that corrects and spatially normalizes whole-brain maps of total N-acetylaspartate (tNAA), myo-inositol (Ins), choline compounds (Cho), glutamate + glutamine (Glx) and creatine + phosphocreatine (tCr). We examined 2 different 3D-MRSI dataset: first, a clinical sample of adolescents and young adults at risk for psychosis (n = 21) meeting DSM-5 criteria for Attenuated Psychosis Syndrome (APS) or Schizotypal Personality Disorder (SCZT), and age-/sex-matched healthy controls (n = 13); and second, a non-clinical sample of adolescents (n = 61) scanned on a different site. The objective of the study was threefold: first, to assess the reproducibility of 3D-MRSI measures across datasets and scanning sites; second, to validate the feasibility of whole-brain, voxel-based analyses on 3D-MRSI data; and third, to test the sensitivity of this approach. Metabolite distributions showed reproducible regional variation in standard space between the two independent samples and scanning sites (r ranging from 0.82 to 0.99). Relative to controls, at-risk participants exhibited higher tNAA levels in frontal grey matter; the SCZT subgroup additionally displayed widespread cortical and subcortical elevations of Ins levels compared with both APS and controls. Voxel-based analyses of structural (i.e., gray and white matter volumes or densities) and diffusion (i.e., generalized fractional anisotropy) parameters yielded no significant differences between patients and controls. These preliminary findings suggest that high-resolution 3D-MRSI may be sensitive enough to detect subtle neurometabolic alterations at the group level in the early stages of psychotic disorders when structural or diffusion measures show no difference. High-resolution whole-brain metabolic mapping may have the potential to help with early identification of young people at risk for psychosis or other mental disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Service of Diagnostic and Interventional Radiology, Department of Medical Radiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
- CIBM Center for BioMedical Imaging, Lausanne, Switzerland.
- Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Division of child and adolescent psychiatry, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Centre Neuchatelois de Psychiatrie, Neuchatel, Switzerland.
ORCID-Profile: Edgar Céléreau, Federico Lucchetti, Yasser Alemán-Gómez, Daniella Dwir, Raoul Jenni, Meritxell Bach Cuadra, Zoé Schilliger, Marco Armando, Kerstin Jessica Plessen, Patric Hagmann, Philippe Conus, Antoine Klauser, Paul Klauser
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Faculté de Biologie et de Médecine, Université de Lausanne
- Adrian & Simone Frutiger Foundation
- Fondation Leenaards
Zitieren
APA
Céléreau, E., Lucchetti, F., Alemán-Gómez, Y., Dwir, D., Cleusix, M., Ledoux, J. B., Jenni, R., Conchon, C., Bach Cuadra, M., Schilliger, Z., Solida, A., Armando, M., Plessen, K. J., Hagmann, P., Conus, P., Klauser, A., & Klauser, P. (2026). High-resolution whole-brain magnetic resonance spectroscopic imaging in youth at risk for psychosis. Imaging Neuroscience, 4. https://doi.org/10.1162/imag.a.1276
Vancouver
Céléreau E, Lucchetti F, Alemán-Gómez Y, Dwir D, Cleusix M, Ledoux JB, et al. High-resolution whole-brain magnetic resonance spectroscopic imaging in youth at risk for psychosis. Imaging Neuroscience. 2026;4. doi:10.1162/imag.a.1276
BibTeX
@article{Clreau2026,
author = {Céléreau, Edgar and Lucchetti, Federico and Alemán-Gómez, Yasser and Dwir, Daniella and Cleusix, Martine and Ledoux, Jean-Baptiste and Jenni, Raoul and Conchon, Caroline and Bach Cuadra, Meritxell and Schilliger, Zoé and Solida, Alessandra and Armando, Marco and Plessen, Kerstin Jessica and Hagmann, Patric and Conus, Philippe and Klauser, Antoine and Klauser, Paul},
title = {High-resolution whole-brain magnetic resonance spectroscopic imaging in youth at risk for psychosis},
journal = {Imaging Neuroscience},
year = {2026},
volume = {4},
doi = {10.1162/imag.a.1276}
}
EUVIMED